Creative Life Science CoROCO:7837 20 EBITDA Margin % is 23.70% as of Dec. 2025, which is 2% above its 10-year median of 23.29. GuruFocus rates ROCO:7837 with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 942 Biotechnology companies, Creative Life Science Co ranks better than 84.71% on this metric.
Creative Life Science Co (ROCO:7837) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Creative Life Science Co EBITDA Margin % Related Terms
Creative Life Science Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7837 vs VRTX, REGN, ALNY: EBITDA Margin % Comparison
For the Biotechnology subindustry, Creative Life Science Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Creative Life Science Co EBITDA Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Creative Life Science Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Creative Life Science Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Creative Life Science Co (ROCO:7837) has a EBITDA Margin % of 23.70% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Creative Life Science Co and its competitors. This is near median its historical median of 23.29. Over the past decade, Creative Life Science Co's EBITDA Margin % has ranged from 21.31 to 28.50. According to the industry distribution chart, Creative Life Science Co ranks #144 out of 942 companies in the Biotechnology industry, placing it in the top 15.3%.
Is Creative Life Science Co's EBITDA Margin % too high?
Creative Life Science Co's current EBITDA Margin % of 23.70% is near median its 10-year median of 23.29. Over the past 10 years, this metric has ranged from a low of 21.31 to a high of 28.50. Based on the distribution chart, Creative Life Science Co ranks #144 out of 942 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Creative Life Science Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Creative Life Science Co's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Creative Life Science Co ranks #144 out of 942 companies for EBITDA Margin %. This places Creative Life Science Co in the top 15% of its industry — outperforming the majority of peers. Historically, Creative Life Science Co's own EBITDA Margin % has ranged from 21.31 to 28.50 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Creative Life Science Co and its competitors. Creative Life Science Co's current EBITDA Margin % is 23.70%, which is near median its own 10-year median of 23.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creative Life Science Co stock overvalued right now?
Creative Life Science Co (ROCO:7837) has a current EBITDA Margin % of 23.70%. The current EBITDA Margin % is 23.70%, which is near median its 10-year median of 23.29. Creative Life Science Co's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Creative Life Science Co (ROCO:7837), the current EBITDA Margin % is 23.70% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Creative Life Science Co Ltd is engaged in providing products of microbiology, and it has prepared media products and diagnostic reagents. The main products of CMP (Creative Media Plate) are solid and liquid media, which can be used for clinical microbiology, basic microbial research, environmental monitoring, biosafety testing, and quality control. Its product line is Transport Medium, Prepared Tube Media, Prepared Plated Media, VTM & I-VTM, Bacterial strain preservation system, and CMP SteriPack triple wrapped media.
20GF Score
Get the complete analysis for ROCO:7837
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7837 has been successfully added to your 